Trans American Aquaculture (GRPS) Change in Accured Expenses (2023 - 2025)
Trans American Aquaculture (GRPS) reported Change in Accured Expenses of -$1.5 million for Q3 2025, down 589.8% on a YoY basis from $302502.0 in Q3 2024, and down 343.74% quarter-over-quarter from $607881.0 in Q2 2025.
Trans American Aquaculture (GRPS) Change in Accured Expenses (2023 - 2025) Analysis & Trends
Trans American Aquaculture has reported Change in Accured Expenses for 3 years, with the latest figure at -$1.5 million in Q3 2025.
- For the quarter ending Q3 2025, Change in Accured Expenses fell 589.8% year-over-year to -$1.5 million; the trailing twelve-month figure through Sep 2025 stood at -$1.6 million (down 310.0% YoY), and the FY2024 full-year result was -$379956.0, down 198.04% from the prior year.
- Change in Accured Expenses for Q3 2025 stood at -$1.5 million, down from $607881.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $607881.0 in Q2 2025, with the low at -$1.5 million in Q3 2025.
- Historically, Change in Accured Expenses has averaged -$75241.0 across 3 years, with a median of $87562.0 in 2023.
- The largest YoY upside for Change in Accured Expenses was 1053.11% in 2025 against a maximum downside of 589.8% in 2025.
- Trans American Aquaculture's Change in Accured Expenses stood at $387549.0 in 2023, then sank by 292.19% to -$744817.0 in 2024, then plunged by 98.93% to -$1.5 million in 2025.
- The last three Change in Accured Expenses figures came in at -$1.5 million (Q3 2025), $607881.0 (Q2 2025), and $38522.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | -14.30 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 23.00 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 14.53 Mn |
| 10 | Trans American Aquaculture | - | - | - | -1.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.48 Mn |
| Sep 30, 2025 | -1.48 Mn |
| Jun 30, 2025 | 607,881.00 |
| Jun 30, 2025 | 607,881.00 |
| Mar 31, 2025 | 38,522.00 |
| Mar 31, 2025 | 38,522.00 |
| Dec 31, 2024 | -744,817.00 |
| Dec 31, 2024 | -744,817.00 |
| Sep 30, 2024 | 302,502.00 |
| Sep 30, 2024 | 302,502.00 |
| Jun 30, 2024 | -63,779.00 |
| Jun 30, 2024 | -63,779.00 |
| Mar 31, 2024 | 126,138.00 |
| Mar 31, 2024 | 126,138.00 |
| Dec 31, 2023 | 387,549.00 |
| Dec 31, 2023 | 387,549.00 |
| Sep 30, 2023 | -177,735.00 |
| Sep 30, 2023 | -177,735.00 |
| Jun 30, 2023 | 90,173.00 |
| Jun 30, 2023 | 90,173.00 |